Clinical Trials

27 enrolled

Phase 1/2 Not yet recruiting

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT07283679 2026-02-24

Phase I/II Trial of ONC-PluReceptor NK Cells With Epcoritamab and Tafasitamab for Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma

Lymphoma, B-Cell

NCT06378190 2026-02-23

TranspoCART19

27 enrolled

Phase 1/2 Not yet recruiting

Lymphoma, B-Cell

NCT07319676 2026-01-23

Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas

Lymphoma, B-Cell

NCT03277729 2026-01-05

A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

53 enrolled 11 charts

Leukemia, Lymphoid, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT06464185 2025-11-18

A Prospective Clinical Study of CD3-CD20 Bisspecific Antibody Based Therapy Combined With CD19-CAR T Cells in the Treatment of Relapsed Refractory B-cell Non-Hodgkin Lymphoma

48 enrolled

Lymphoma, B-Cell

NCT04074746 2025-09-30

Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas

45 enrolled

Mycosis Fungoides, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic

NCT03147885 2025-09-29

Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma

43 enrolled

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT04697940 2025-09-19

Decitabine-primed Tandem CD19/CD20 CAR T Cells Treatment in r/r B-NHL

33 enrolled

Recurrence, Lymphoma, B-Cell

NCT06213636 2025-08-06

BAH241

75 enrolled

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07097207 2025-07-31

CAR-T

20 enrolled

Lymphoma, B-Cell

NCT06045910 2025-07-28

A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies

84 enrolled

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Neoplasms, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT07009002 2025-06-25

BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma

Lymphoma, B-Cell

NCT06987916 2025-06-05

Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma

50 enrolled

Phase 1/2 Not yet recruiting

Recurrence, Lymphoma, B-Cell

NCT06767956 2025-06-04

Golcadomide and Nivolumab in Patients With Non-Hodgkin Lymphoma With Refractory Disease After Chimeric Antigen T-cell Therapy

Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT04544592 2025-05-04

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

45 enrolled

Burkitt Lymphoma, Lymphoma, B-Cell

NCT01701986 2025-02-28

Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

64 enrolled 13 charts

Hodgkin Disease, Lymphoma, B-Cell, Lymphoma, T-Cell

NCT06834529 2025-02-19

CAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and Lymphoma

20 enrolled

Lymphoma, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell

NCT05936229 2024-07-12

Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell Therapy

Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Mantle-Cell

NCT02628405 2024-07-01

R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma

30 enrolled 15 charts

Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT06002659 2024-05-09

CARMA-01

18 enrolled

Lymphoma, B-Cell

NCT03098355 2024-03-18

Interleukin-2 Following 4SCAR19/22 T Cells Targeting Refractory and/or Recurrent B Cell Malignancies

Leukemia, B-Cell, Lymphoma, B-Cell

NCT05613348 2024-03-18

CAR19T2

Burkitt Lymphoma, Lymphoma, Lymphoma, B-Cell

NCT05932173 2023-07-11

A Study of Novel Anti-CD19 CAR-T in Patients With r/r B-Cell Malignancies

60 enrolled

Leukemia, Lymphoma, Leukemia, B-Cell, Lymphoma, B-Cell

NCT05771883 2023-05-24

A Clinical Study of Injectable IMM0306 in Combination With Lenalidomide

102 enrolled

Lymphoma, B-Cell

NCT05842707 2023-05-06

Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma

48 enrolled

Lymphoma, B-Cell

NCT05776407 2023-03-20

Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma

12 enrolled

Lymphoma, B-Cell

NCT05570188 2022-11-30

Anti-CD19 Universal CAR-NK Cells Therapy Combined With HSCT for B Cell Hematologic Malignancies

Leukemia, B-Cell, Lymphoma, B-Cell

NCT02898259 2022-09-26

Lenalidomide, Ixazomib, and Rituximab as Front-Line Therapy for High Risk Indolent B-Cell Lymphoma

Phase 1/2 Terminated

19 enrolled 15 charts

Lymphoma, Lymphoma, B-Cell

NCT03704714 2022-08-15

Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma

Phase 1/2 Suspended

Lymphoma, B-Cell

NCT02481310 2022-02-21

Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma

38 enrolled 12 charts

Plasmablastic Lymphoma, Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT02933320 2021-07-08

BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia

14 enrolled 17 charts

Waldenstrom Macroglobulinemia, Leukemia, B-Cell, Lymphoma, B-Cell

NCT04747093 2021-02-10

Induced-T Cell Like NK Cells for B Cell Malignancies

12 enrolled

Burkitt Lymphoma, Leukemia, B-Cell, Lymphoma, B-Cell

NCT01921387 2020-08-04

Radiolabeled Monoclonal Antibody and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With High-Risk Lymphoid Malignancies

20 enrolled 12 charts

Hodgkin Disease, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, Mantle-Cell

NCT02547948 2020-07-16

CD19-targeting CAR T Cells for B Cell Lymphoma

Lymphoma, Lymphoma, B-Cell

NCT04429438 2020-06-12

Multi-CAR-T Cells Targeting B Cell Lymphomas

11 enrolled

Lymphoma, B-Cell

NCT01626495 2020-03-23

Pedi CART19

73 enrolled 12 charts

Leukemia, B-Cell, Lymphoma, B-Cell

NCT01788189 2020-02-26

LeMLAR

37 enrolled

Lymphoma, Recurrence, Lymphoma, B-Cell

NCT00294632 2020-02-24

Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma

54 enrolled 9 charts

Lymphoma, Lymphoma, Follicular, Lymphoma, B-Cell, Lymphoma, Mantle-Cell

NCT02983097 2018-01-19

R²-DHAP

Phase 1/2 Terminated

34 enrolled

Burkitt Lymphoma, Lymphoma, Recurrence, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT00156013 2017-11-29

Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL)

33 enrolled 9 charts

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT02132624 2017-10-30

CD19-targeting 3rd Generation CAR T Cells for Refractory B Cell Malignancy - a Phase I/IIa Trial.

15 enrolled

Leukemia, B-Cell, Lymphoma, B-Cell

NCT03166878 2017-06-23

A Study Evaluating UCART019 in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma

80 enrolled

Leukemia, B-Cell, Lymphoma, B-Cell

NCT03146533 2017-05-17

CD19 CART Cells for Patients With Relapse and Refractory CD19+ B-cell Lymphoma.

20 enrolled

Lymphoma, B-Cell

NCT00761384 2016-02-19

HITT

7 enrolled

Recurrence, Lymphoma, B-Cell

NCT02134262 2014-11-06

Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes

18 enrolled